L3Harris's Landmark PAC-3 Contract Settles Demand — Not Valuation

In late July, L3Harris signed what it calls its largest-ever PAC-3 Missile Segment Enhancement propulsion agreement with the U.S. Department of War and Lockheed Martin — a seven-year framework to nearly triple production of the components that steer and power Patriot interceptors. It is the kind of headline a defense investor is told to love: the "arsenal of freedom" in contract form. What it actually does to the stock is more complicated, because the headline settles the demand but leaves the price unresolved.

The contract covers the two-pulse solid rocket motor, the attitude control motors that make the PAC-3 MSE maneuver, and the lethality enhancer that widens its kill radius. A concurrent agreement does the same for THAAD interceptor propulsion. The mechanism that matters is the "multi-year procurement" authority behind it: instead of buying missiles one yearly budget at a time, the government commits to a stable seven-year production line. For a manufacturer that has to sink money into capacity before the orders arrive, that stability is the whole game. L3Harris is investing billions across roughly 60 facilities — almost a million square feet of new and upgraded space in Alabama, Virginia, and Arkansas — to nearly triple motor output. The deal has not yet been "definitized", and the dollar value has not been disclosed.

That last point is worth holding onto, because it sets expectations. L3Harris runs a roughly $23 billion-a-year revenue business with $42 billion in backlog. A propulsion award, even the largest this company has signed for PAC-3, is absorbed into that backlog rather than announced as a single headline number the market can price. This is demand visibility — a multi-year revenue runway and a stronger case that cash flow will keep funding the payout — more than it is a one-day catalyst.

That distinction matters because of how the equity curve funnels into the rest of the story. This is a real-economy, mission-critical business: if the Patriot system is the world's most battle-tested anti-missile shell, L3Harris makes the muscles inside it, and it recently grew its Missile Solutions revenue 14% year over year. In the current environment, that is precisely the kind of structural, hard-asset demand a running-hot-inflation thesis wants to own. But the "toll-booth" appeal of defense is exactly why valuation discipline matters here, not less.

Consider what you are paying relative to the primes. L3Harris trades at roughly 16 times EV/EBITDA and about 26 times trailing earnings. Northrop Grumman sits around 14 times and 16 times, General Dynamics near 15 and 22, Lockheed Martin under 13 times EV/EBITDA and about 19 times earnings. L3Harris is the smaller, faster-growing name and often deserves a premium. But it already carries one, so the question is whether the growth the missile line is delivering justifies it — not whether the contract proves the demand exists. On disclosed 2026 guidance of $11.80 to $12.00 of earnings per share, the stock near $256 sells for roughly 21–22 times forward earnings. That is not a bargain; it is a fair-to-rich price for a company whose recent history has been noisy.

That noise is the part the reader has likely already seen. The shares sit near their 52-week low, down more than 12% year to date, after the board replaced chairman and CEO Christopher Kubasik in August following an investigation, and after a U.S.–Iran diplomatic agreement knocked the defense sector down in June. A dividend-growth investor should treat that price decline as an outcome, not as evidence. The PAC-3 contract, the $42 billion record backlog, and a book-to-bill of 1.2x say the underlying demand did not soften; sentiment and governance headlines moved the price instead.

That gap — real contracted demand, falling price — is where the equity yield curve argument gets interesting, with one honest caveat. L3Harris pays a modest dividend, roughly 2%, with a payout near half of earnings and a free cash flow of about $2.8 billion that covers it comfortably. It has raised the dividend for 23 consecutive years. The multi-year contract strengthens that durability: a company that knows its production line is funded for seven years has less reason to cut the payout in a bad year. But this is a growth-and-backlog story, not an income story. At a 2% yield you are not being paid to wait; you are buying a bet that a real-economy monopoly supplier grows its earnings and its dividend for a decade.

So what does the landmark contract actually settle? It settles the demand question — for the PAC-3 propulsion line, demand is now contracted, visible, and large enough to justify a billion-dollar capacity build. It does not settle the valuation question, which remains a premium to the primes on an un-disclosed deal, and it does not settle the governance question that pushed the shares to their low. The opportunity here is the confession embedded in the falling price: the market is pricing L3Harris like a defense stock mid-scandal and mid-peace-deal, while the balance sheet, backlog, and now this contract describe a business compounding on fully funded demand. That is a real setup. It just asks you to buy the noise at a defense-multiple premium — and only if you can hold through the cycle volatility the sellers just demonstrated.